Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Copy number polymorphisms and anticancer pharmacogenomics
Eric R. Gamazon
,
R. Stephanie Huang
, M. Eileen Dolan
, Nancy J. Cox
Experimental and Clinical Pharmacology
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Copy number polymorphisms and anticancer pharmacogenomics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticancer
100%
Copy number Variation
100%
Copy number Polymorphism
100%
Pharmacogenomics
100%
Single nucleotide Polymorphism
33%
Genetic Variation
22%
Drug Response
22%
Pharmacologic
22%
Cellular Sensitivity
22%
Scientific Community
11%
Gene Expression
11%
Cell-based
11%
Neurodevelopmental Disorders
11%
Treatment Regimen
11%
Crohn's Disease
11%
Drug Sensitivity
11%
Systemic Lupus Erythematosus
11%
Structural Variants
11%
Population Scale
11%
Copy number
11%
Disease Susceptibility
11%
Topoisomerase Inhibitors
11%
Complex Disorders
11%
Expression Quantitative Trait Loci (eQTL)
11%
Array-based
11%
Community Relationships
11%
Genome-wide Studies
11%
Anticancer Treatment
11%
Drug Association
11%
Pharmacogenomic Studies
11%
Platinating Agents
11%
Complex Trait Genetics
11%
Genome-wide Methods
11%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
100%
Pharmacogenomics
100%
Anticancer
100%
Genetic Variation
66%
Drug Response
66%
Genetic Divergence
33%
Expression Quantitative Trait Loci
33%
Genetics of Complex Trait
33%
Gene Expression
33%
Drug Sensitivity
33%
Pharmacogenetic Testing
33%
DNA Gyrase
33%